Vectura Share Discussion Threads

[pooroldboy55] 12/3/2020 09:15

It will turn but when ?

[polaris] 12/3/2020 08:53

All bets are off in this market and it's up to you to decide what to do. It's nothing stock specific. This is full-on crash now.

[kolosos] 12/3/2020 08:43

Less to do with this stock, more to do with the general market.

[insideryou] 12/3/2020 08:38

Battered. Com. Where can this end.

[polaris] 10/3/2020 18:19

Tranche 2 will likely start immediately following results. They may make other returns depending on what they need as working capital. Over 10 M bought back and cancelled now. They could easily add another £20 M in addition to £10 M tranche 2 from existing cash pile. If they win v GSK then it's probably another special dividend of at least $100 M.

[cockneytrader] 10/3/2020 17:12

Another £20 million towards share buy backs is required. You buy back shares only when you have a cash surplus and shares are cheap.

[polaris] 10/3/2020 15:44

I've trimmed due to market conditions as previously stated and so I'm not planning to add more unless there is a market turnaround. Right now, nothing makes any sense and the short termism is the leading indicator, irrespective of company prospects.

[insideryou] 10/3/2020 15:15

Back to Sept 19 levels. Frustrating for you Paul or a buying opp?

[polaris] 09/3/2020 07:47

Another new position. VEC building up their team for the new strategy. I suspect that will go unnoticed today. It's going to be a real tin hat day.

[cockneytrader] 08/3/2020 20:35

With regard to supply chains, see page 44 of 2018 report and accounts. Although the risks are based on a hard Brexit they are not too dissimilar to a hard COVID. Specifically mentioned is movement of product in and out of ports.

[cockneytrader] 08/3/2020 19:50

I am not optimistic how the COVID will play out. Although Vectura seems a safe haven, I am not certain about supply chains going forward. Results in March will be good with a healthy cash surplus. The share price is unlikely to go up, and in my view should be supported during 2020 with another £10 or £20 million share buy back.

[dukew1] 08/3/2020 13:52

Agree that the virus will not have a direct impact on the company/ unless certain regulatory authorities are impacted in terms of ability to approve/review submissions. I'm interested to see what the new executive angle will lead to moving away from flutiform with there being a time span on how long this will be directly revenue generating. Nebuliser tech is here for a while and it would be great to see some fruition from that to guarantee the future past FF.

[diesel] 08/3/2020 12:11

Base, good to be positive in these troubled times. Not sure that Covid 19 will have any direct impact on our product sales, for me it’s ‘let the trend be your friend’. I was poised to add a few more on recent weakness but missed, there will be other opportunities with the markets remaining volatile for some time yet. It would be good to see some benefits from the new executive management post, maybe the results will set out a clearer strategy in that area.

[base7] 08/3/2020 11:42

I appreciate your rationale ,Polaris,in reducing your large holding to 150k.I have tratined my large holding @ more than 2X your holding -a very substantial holding for me,particularly in these uncertain times.However I liquidated various holdings 6/7 weeks ago & find myself with some liquidity in my SIPP/ISA & while also having more exposure to gold I am tempted to buy even more Vec ahead of results (on 17/3),depending on our share price over the next few days.We are well funded,a lower risk strategy which should result in increasing rnevenue,cash flow & profitability with reduced R&D expenditure resulting in near term increased profitability & the possibility of inaugural dividends.I anticipate our Fluti sales possibly exceeding expectations for this year based on increased demand in all of our Markets due the continuing threat from Covid-19 & the vulnerability of asthma sufferers .My view is that positive outcomes from generic Advair,$200mill from GSK,$32mill from Pacira are not yet priced into our share price I appreciate maybe best to wait a few weeks before adding when Markets will have ,hopefully,stabilised & even more hopefully generic Advair has received approval -but our share price may have ,by then ,started rushing ahead of anticipated positive news & following a more positive outlook Statement with Interims than currently anticipated.
I appreciate that my vie may be considered irrationally positive in these dark times but I have always been a glass half full skirt of guy

[polaris] 06/3/2020 17:20

It's one small UT way above last recorded AT trade in the auction. I wouldn't count too much on it.

[base7] 06/3/2020 17:18

Didn’t expect to end the day blue after the earlier falls -let’s hope there is a sound reason for the small increase on an awful day for the markets

[polaris] 06/3/2020 13:15

@a1ord53 - I think that you can pay for access to the submitted briefs but there is little point IMO. A link to a service was posted not too long ago that purports to provide this access.

Judge will not make any rulings until the reply to brief from VEC is submitted in April.

I expect a lot of relevant news for VEC in 2020, but weighted to H2: VR315, QVM149, GSK litigation, CDMO update, Ellipta generic device update, leverage of VEC IP to new APIs and further clarity on Pacira sales growth of Exparel towards the $500 M level for the $32 M milestone.

[polaris] 06/3/2020 13:10

With most recent buybacks the tranche 1 is due to complete either Friday next week or Monday the week after - i.e. before the results date of Tuesday 17th. Total commited now a tad under £8.86 M and 9.818 M shares, average price 90.23 p.

The markets are all over the place and it is anyone's guess how things will evolve. I've trimmed holdings to the 150 k level and added producing gold miners in recent weeks, to balance risk.

Roll on the results and the update...and tranche 2 of the buyback!

[pooroldboy55] 04/3/2020 12:00

Could just be I'm in the Limousin for the past 10 day's and has rained every day !!!
Cheers
A
PS you wouldn't want a leaky ship here it would sink.

[polaris] 04/3/2020 11:31

'Ello 'ello! What's all this then? Spike in volume and a move up...leaky ship?

[greenc] 04/3/2020 09:42

Not directly relevant, but a US Law headline on Monday very much indicates that theft of small pharma's IP would appear to be embedded in GSK's dna, and they don't always get away with it :

'GSK Settles Anemia Drug Patent Claims On Eve Of Trial

British pharmaceutical giant GlaxoSmithKline settled claims it infringed two patents for anemia treatments with patent holder FibroGen Inc. and licensee Astellas Pharma just as the case went to trial Monday in London.'

The case is listed to continue this morning in the London Patents Court, but that may not take account of the above.

[fhmktg] 04/3/2020 09:40

Any expert opinion on whether Flutiform has a part to play in easing the side effects of Covid-19?

[polaris] 28/2/2020 17:18

(i) yes
(ii) yes
(iii) How long is a piece of string? Probably sometime in H2 2020. Depends on how the appeal goes i suppose.

[justiceforthemany] 28/2/2020 17:14

Sorry this question may have been answered already but (i) have GSK officially launched their appeal (ii) is it ongoing as of now? (iii) When can we expect a verdict on the damages being awarded?

[polaris] 28/2/2020 12:32

fhmktg - normal expectation is 6 months, the same as a new submission.